Valeant Pharmaceuticals International, Inc.

URI: https://gptkb.org/entity/Valeant_Pharmaceuticals_International,_Inc.
GPTKB entity
Statements (30)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:acquiredBy gptkb:Bausch_&_Lomb
gptkbp:acquisitionYear 2013
gptkbp:countryOfOrigin gptkb:Canada
gptkbp:founded 1960
gptkbp:founder gptkb:Milan_Panić
gptkbp:headquartersLocation gptkb:Laval,_Quebec,_Canada
https://www.w3.org/2000/01/rdf-schema#label Valeant Pharmaceuticals International, Inc.
gptkbp:industry pharmaceuticals
gptkbp:keyPerson gptkb:Joseph_C._Papa
gptkb:J._Michael_Pearson
gptkbp:notableEvent subject of U.S. Senate investigations
involved in major accounting and pricing controversies
gptkbp:numberOfEmployees ~22,000 (2016)
gptkbp:products medical devices
over-the-counter drugs
prescription drugs
gptkbp:renamed gptkb:Bausch_Health_Companies_Inc.
2018
gptkbp:successor gptkb:Bausch_Health_Companies_Inc.
gptkbp:tradedOn gptkb:NYSE:_VRX
gptkb:TSX:_VRX
gptkbp:website www.valeant.com
gptkbp:bfsParent gptkb:Biovail_Corporation
gptkb:Bausch_Health_Companies_Inc.
gptkb:Biovail
gptkb:VRX
gptkb:NYSE:BHC
gptkb:TSX:BHC
gptkbp:bfsLayer 7